Clínic-IDIBAPS researchers present around 40 studies at ESMO 2024
One of the highlights of the Clínic-IDIBAPS participation in the European Society for Medical Oncology (ESMO) 2024 Congress was Dr. Josep M. Llovet...
One of the highlights of the Clínic-IDIBAPS participation in the European Society for Medical Oncology (ESMO) 2024 Congress was Dr. Josep M. Llovet...
September 1st is World Chronic Lymphocytic Leukaemia (CLL) Day, the most common leukaemia in adults. Most patients with CLL respond well to treatme...
Els Pets, Quimi Portet, Gerard Quintana, Pemi Fortuny & Pemi Rovirosa (Lax’N’Busto), Joan Masdéu, among others, will participate in the tribute con...
She started working at the Hospital Clínic Barcelona five years ago and has been the new head of the Gynaecology Service for three months. In rece...
A recent report from an organisation linked to the WHO states that talc is probably carcinogenic to humans. The use of talc is considered to increa...
A study by the Clínic-IDIBAPS shows that silencing this gene reduces the growth of liver cancer in mice. The research, using different animal model...
The Committee for the Evaluation of Medicinal Products for Human Use of the Spanish Agency of Medicines and Medical Devices (AEMPS) has approved AR...
A study promoted by SOLTI and published in Nature Communications describes the tumour biology associated with the activity of the drug patritumab d...
This year, FERO will contribute €200,000, with which it will seek to provide structural and sustained support for the Molecular Diagnostics Program...
On 27 June 2024, a social return event was held at the TV3 facilities, thanking the public for the television marathon devoted to cancer.